INS and metabolic dysfunction-associated steatotic liver disease: Furthermore, it was reported that the activation of lipogenesis, which is the physiological action of insulin in the liver, remains in animal models fed high fat diets [51] and in NAFLD patients [52] despite systemic insulin resistance.